LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAG’s new chief executive officer, will present at two investor conferences in June. The presentations will include a company overview and a review of the company’s growth opportunities.
